United Therapeutics Corporation UTHR
Price alert —
Sign in to get a one-time email the moment UTHR crosses your price. Free accounts included.
Sign in / create a free accountUnited Therapeutics Corporation is a healthcare company listed in the US.
UTHR last traded at $535.67, up 1.2% on the day; that's in the middle part of its 52-week range ($455.63–$609.35). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 44), the trend is quiet (ADX 18), and volume is about normal (0.8×). On the business side, revenue is shrinking 2% year over year and the business keeps about 18 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $209.54 (fair range $210–$489); today's price sits 154% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 4.47 (antifragile)
- ✓ Current ratio 6.60 (antifragile)
- ✓ Debt/equity 0.11 (antifragile)
- ⚠ Receivables growing faster than revenue
- ⚠ Inventory growing faster than revenue
Price implies ~17% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
UTHR is a $22.7 billion company, priced at 20× last year's earnings.